News
November 2011 - HAI Europe and Trans Atlantic Consumer Dialogue (TACD) organized an expert conference to examine how the EU Commission's Research and Innovation Framework programme – Horizon 2020, will invest in economically and socially sustainable innovation models. Read more.
July 2011 - HAI Europe welcomes the Gilead licensing agreement with the Medicines Patent Pool. On 12 July 2011 the Medicines Patent Pool announced its first licences to increase access to HIV and Hepatitis B treatment in developing countries. Read more.
Publications
29 November 2011Executive Summary EU Policy Opportunities in Biomedical Innovation and the Public Good
29 June 2011
Joint-Open-Letter-Common-Strategic Framework (EN)
22 June 2011
An Essential Health and Biomedical R&D Treaty
20 May 2011
Consultation Response DG Research Green Paper
29 November 2010
Joint Statement Increasing Calls Within EU for New Models of Medical Innovation
Policy Briefs & Reports
October 2009 Joint HAI Europe - Oxfam Report Trading Away Access to Medicines (EN) (FR) (ES)
March 2009 Advanced Market Commitments: Current Realities & Alternate Approaches